Aghib Deborah F. 4
4 · Stellar Biotechnologies, Inc. · Filed Jan 25, 2018
Insider Transaction Report
Form 4
Aghib Deborah F.
Director
Transactions
- Award
Share Option (Right to Buy)
2018-01-23+2,500→ 2,500 totalExercise: $0.93Exp: 2025-01-23→ Common Shares (2,500 underlying)
Footnotes (1)
- [F1]Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third on January 23, 2019, as to one-third on January 23, 2020 and as to the remaining one-third on January 23, 2021.